|
AP3B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57790003285641E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77839998283247E-09 |
| Normal-vs-Stage2 |
2.018200E-03 |
| Normal-vs-Stage3 |
5.817400E-03 |
| Normal-vs-Stage4 |
3.036500E-03 |
| Stage1-vs-Stage2 |
8.937400E-01 |
| Stage1-vs-Stage3 |
5.864600E-01 |
| Stage1-vs-Stage4 |
6.599200E-01 |
| Stage2-vs-Stage3 |
7.730600E-01 |
| Stage2-vs-Stage4 |
5.901600E-01 |
| Stage3-vs-Stage4 |
4.792200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.89850390753099E-11 |
| Normal-vs-AfricanAmerican |
1.50088999999465E-05 |
| Normal-vs-Asian |
5.790800E-01 |
| Caucasian-vs-AfricanAmerican |
5.249000E-01 |
| Caucasian-vs-Asian |
3.178000E-01 |
| AfricanAmerican-vs-Asian |
4.522000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0778045123061E-11 |
| Normal-vs-Female |
8.421800E-04 |
| Male-vs-Female |
1.643860E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.05539999961657E-07 |
| Normal-vs-Extreme_Weight |
1.26609833728253E-11 |
| Normal-vs-Obese |
2.4162999999966E-05 |
| Normal-vs-Extreme_Obese |
2.350000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.963200E-01 |
| Normal_Weight-vs-Obese |
1.518200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.732400E-01 |
| Extreme_Weight-vs-Obese |
7.710300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.549200E-01 |
| Obese-vs-Extreme_Obese |
5.069400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.356700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.61260000020036E-07 |
| Normal-vs-Age(61-80Yrs) |
3.69430042113095E-10 |
| Normal-vs-Age(81-100Yrs) |
1.91103999999109E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.285000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.667200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.802600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.924840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.786200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.281800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.34760022322212E-11 |
| Normal-VS-Type2 PRCC |
3.83000000000466E-05 |
| Normal-VS-KIRP CIMP |
1.81045999999574E-05 |
| Normal-VS-Unclassified PRCC |
1.643810E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.163400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.460400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.162010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.436200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.651000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.925600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10740000003329E-06 |
| Normal-vs-N1 |
3.579500E-03 |
| Normal-vs-N2 |
4.179800E-04 |
| N0-vs-N1 |
2.808200E-01 |
| N0-vs-N2 |
7.961600E-01 |
| N1-vs-N2 |
3.765600E-01 |
|
|
